Key result
ACE D/D genotype strongly associates with cephalalgic, asthenic, and extrapyramidal syndromes in CVE patients.
Why the study?
Is there a relationship between clinical syndromes and gene polymorphisms of ACE and AT2R1 genes in patients with chronic vascular encephalopathy?
Observational (n=145)
Is there a relationship between clinical syndromes and gene polymorphisms of ACE and AT2R1 genes in patients with chronic vascular encephalopathy?
The ACE D/D genotype is strongly associated with cephalalgic, extrapyramidal, and asthenic syndromes in patients with chronic vascular encephalopathy.
Answers are grounded in this paper and cite their sources.
ACE D/D association with CVE syndromes is hypothesis-generating; prospective studies needed before any clinical genotyping role.
This article presents the results of the study of relationships between clinical presentation and polymorphism of the ACE and AT2R1 genes in patients with chronic vascular encephalopathy (CVE). The 145 patients with chronic vascular encephalopathy (CVE) were examined in order to analyze the clinical presentation of the disease. The molecular genetic research was performed in 18 patients. After the complete clinical and neurological examination, such frequency of the syndromes was found: cephalalgic (70.34 %), extrapyramidal (60.00 %), vestibular (61.38 %), asthenic (53.79 %) syndromes, and syndrome of cognitive disorders (66.21 %). When assessing the dependence of the clinical syndromes most often found in patients with CVE on the I/D polymorphism of the ACE gene, it was established that 90.91 % of patients with cephalalgic syndrome, 81.82 % of patients with asthenic syndrome, and 90.91 % of patients with extrapyramidal syndrome are carriers of the D/D genotype. In contrast, all patients with the absence of cephalalgic, extrapyramidal, and asthenic syndromes had the I/I ACE gene genotype. No significant correlations were found between the presence/absence of clinical syndromes and the frequency distribution of genotypes and alleles of the A1166C polymorphic variant of the AT2R1 gene in patients with CVE.
No takes yet. Share an insight, caveat, or question.
Khrystyna Duve (2023) conducted an observational in Chronic vascular encephalopathy (n=145). ACE and AT2R1 gene polymorphisms was evaluated on Relationships between clinical syndromes and gene polymorphisms of ACE and AT2R1 genes. The D/D genotype of the ACE gene was highly prevalent in CVE patients with cephalalgic, asthenic, and extrapyramidal syndromes, whereas those without had the I/I genotype.
Synapse has enriched 10 related papers. Consider them for comparative context: